IDH1 and acute myeloid leukemia: Evidence that TET2 and IDH1/2 mutations are mutually exclusive in AML tumours [79] supports the notion that TETs inhibition and the ensuing DNA hypermethylation are instrumental to IDH-driven tumorigenesis.